Our New Fragment-To-Lead Drug Discovery Service Has Launched Visit the page to learn more and download the white paper
Nature publishes Bioblocks' collaborative paper presenting fragment-based technology. View the paper in Nature Communications Read a summary in Chemistry Community
Genesis Biotechnology Group Acquires BioBlocks to Grow the Preclinical Chemistry Services Portfolio of Genesis Drug Discovery & Development (GD3)View Press Release
Having the right chemistry partner is a must for the complex journey of drug discovery.
Extend your team. Integrate with ours.
Having the right chemistry partner is a must for the complex journey of drug discovery.
Extend your team. Integrate with ours.
Skilled People
Skilled People
Technology
Technology
Value Proposition
Value Proposition
Contact Us
Contact Us